S
Sirrus
Develops innovative monomer platforms
About Sirrus
Sirrus Chemistry specializes in the development of advanced methylene malonate crosslinkers, which are used to create superior coatings, adhesives, sealants, and encapsulants. The company serves a wide range of industries including automotive, packaging, wood products, construction, medical, and electronics. Sirrus operates in the specialty chemicals market, focusing on enhancing product performance and reducing environmental impact. Their business model involves partnering with formulators and manufacturers to integrate their unique chemical solutions into various products. Revenue is generated through the sale of these specialized chemical compounds and through licensing agreements. Sirrus aims to drive innovation in product formulations, offering benefits such as rapid polymerization at ambient temperatures, reduced energy requirements, and lower solvent usage.
Source: Dealroom company dataAt a glance
- Founded
- 2009
- Headquarters
- Loveland, United States
- Sector
- Energy
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
CincyTech
Braemar Energy Ventures
Arsenal
Mitsui Global Investment
GM Ventures
QCA Ventures
Series B and later2 investors entered at this stage
Square 1 Bank
Trinity Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sirrus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sirrus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.